New Issue: UBS prices $468,000 trigger return optimization securities linked to Gilead Sciences

New York, Feb. 10 – UBS AG, London Branch priced $468,000 of trigger return optimization securities due Feb. 17, 2017 linked to the common stock of Gilead Sciences, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

If Gilead Sciences stock closes at or above the initial price, the payout at maturity will be par plus three times any gain in common stock of Gilead Sciences capped at 42.33%.

Investors will share in any losses.

UBS Financial Services Inc. and UBS Investment Bank are the underwriters.

Issuer:	UBS AG, London Branch
Issue:	Trigger return optimization securities
Underlying stock:	Gilead Sciences, Inc. (Nasdaq: GILD)
Amount:	$468,000
Maturity:	Feb. 17, 2017
Coupon:	0%
Price:	Par of $10
Payout at maturity:	Par plus three times any gain in common stock of Gilead Sciences, capped at 42.33%; otherwise, exposure to any losses
Initial share price:	$98.32
Pricing date:	Feb. 10
Settlement date:	Feb. 13
Underwriters:	UBS Financial Services Inc. and UBS Investment Bank
Fees:	2%
Cusip:	90274M150

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.